Abstract:Studies from recent years have identified a diverse population of both bacteria and fungi in the human vagina and several community signatures have emerged that are associated with susceptibility to infectious disease. A healthy vaginal bacterial microbiome is most frequently dominated by Lactobacillus species [1], yet a combination of other genera are isolated in vaginal swabs in both healthy and diseased states. The vaginal fungal mycobiome is dominated by Ascomycota, of which Candida species are the most abundant. Approximately 20% to 30% of healthy human vaginal samples contain detectable Candida at a single time point, with nearly all of those being C . albicans , and 70% of the population is expected to be vaginally colonized with Candida longitudinally [2]. Despite its prevalence in the healthy vaginal mycobiome, C . albicans is the most common causative agent of vulvovaginal candidiasis (VVC), a cause of significant morbidity in the human population. The next most common species implicated in VVC is C . glabrata , while other species including C . lusitaniae , C . tropicalis , C . parapsilosis , and C . krusei are also known to contribute to vaginal infections [3–5]. Non- albicans Candida species are typically more resistant to antifungal drugs than C . albicans [6], complicating therapeutic options and increasing treatment timelines. A disease state is often distinguished by an exaggerated inflammatory response at the vaginal mucosa [3] that leads to vulvar pruritis and erythema [7]. Polymorphic Candida species can initiate the process of filamentation, morphogenesis from single-celled yeast to multicellular hyphae, which is typically accompanied by increased tissue damage and inflammation [8]. Microbial dysbiosis has long been associated with VVC due to the observation that antibiotic usage dramatically increases the risk of onset. This notion has been challenged by several population studies [9,10]; however, other studies have found a close association between Candida and specific bacteria as well as distinct Lactobacillus species that were associated with decreased observation of fungi in samples or symptomatic VVC [11–15]. Taken together, the evidence suggests that specific bacterial species can have complex impacts on fungal burden and symptomatic infection. Shifts in the vaginal microbiome are also associated with other genital tract infections [13,16] including bacterial vaginosis (BV) and aerobic vaginitis (AV), which are characterized by the displacement of Lactobacillus species by other bacteria such as Gardnerella vaginalis , Streptococcus agalactiae , Staphylococcus aureus , Escherichia coli , and Enterococcus faecalis [17]. Both BV and AV are polymicrobial in nature and are associated with concurrent Candida carriage in many cases [18,19]. Mixed vaginitis, which can include BV or AV together with VVC, is particularly difficult to treat, and during late stages of pregnancy can lead to severe adverse maternal and neonatal outcomes [17,20]. Because it is the most abundant fungal genus in the vagina, this review will focus on the interactions between Candida species and the healthy and pathogenic bacteria found in the vaginal environment. These interactions play a significant role in maintaining homeostasis as well as impacting disease pathogenesis in the genital tract (Fig 1).

Clinical Significance of Composition and Functional Diversity of the Vaginal Microbiome in Recurrent Vaginitis

[Longitudinal Analysis of Vaginal Microbiota in Women with Recurrent Vulvovaginal Candidiasis].

Molecular Analysis of the Diversity of Vaginal Microbiota Associated with Bacterial Vaginosis

Species composition and dynamic changes of vaginal microbiota in patients with recurrent vulvovaginal candidiasis

Diverse Vaginal Microbiomes in Reproductive-Age Women with Vulvovaginal Candidiasis.

Highlight signatures of vaginal microbiota and metabolome contributed to the occurrence and recurrence of vulvovaginal candidiasis

Diversity of Cervicovaginal Microbiota Associated with Female Lower Genital Tract Infections

Interpretation of vaginal metagenomic characteristics in different types of vaginitis

Analysis of the structure of vaginal microbiota in vulvovaginal candidiasis

Associations Between Vaginal Pathogenic Community And Bacterial Vaginosis In Chinese Reproductive-Age Women

Associations Between Bacterial Vaginosis, Candida Vaginitis, Trichomonas Vaginalis, And Vaginal Pathogenic Community In Chinese Women

Vaginal microbiome of reproductive-age women

Impact of interkingdom microbial interactions in the vaginal tract

Increased Diversity of Fungal Flora in the Vagina of Patients with Recurrent Vaginal Candidiasis and Allergic Rhinitis

Comparative study of vaginal microflora of VVC and RVVC patients before and after treatment

Potential Association between Vaginal Microbiota and Cervical Carcinogenesis in Korean Women: A Cohort Study

Analysis of vaginal micro-ecological status in 4019 clinical patients with different symptoms

Association between vaginal microbiota and vaginal inflammatory immune markers in postmenopausal women

Illumina Sequencing 16S Rrna Tagging Reveals Diverse Vaginal Microbiomes Associated with Bacterial Vaginosis

Vaginal Bacterial Profiles of Aerobic Vaginitis: a Case–control Study

Prevalence of Pathogens and Other Microorganisms in Premenopausal and Postmenopausal Women with Vulvovaginal Symptoms: A Retrospective Study in a Single Institute in South Korea